Psychiatry at Rhode Island Hospital

MIDAS Project

Publications

Following is a listing of published research and related abstracts. A listing of additional research that has been submitted for publication is also available. 

  1. Zimmerman, M., Mattia, J.I. Body dysmorphic disorder in psychiatric outpatients: Recognition, prevalence, comorbidity, demographic, and clinical correlates. Comprehensive Psychiatry, 1998, 39, 265-270.
    (abstract)

  2. Zimmerman, M., Mattia, J.I. Psychiatric diagnosis in clinical practice: Is comorbidity being missed? Comprehensive Psychiatry, 2005, 40, 182-191.
    (abstract)

  3. Zimmerman, M., Mattia, J.I. Is posttraumatic stress disorder underdiagnosed in routine clinical settings? Journal of Nervous and Mental Disease, 2005, 187, 420-428.
    (abstract)

  4. Zimmerman, M., Mattia, J.I. Psychotic subtyping of major depressive disorder and posttraumatic stress disorder. Journal of Clinical Psychiatry, 2005, 60, 311-314.
    (abstract)

  5. Zlotnick, C., Mattia, J.I., Zimmerman, M. Clinical correlates of self-mutilation in a sample of general psychiatric patients. Journal of Nervous and Mental Disease, 2005, 187, 296-301.
    (abstract)

  6. Zimmerman, M., Mattia, J.I. Axis I diagnostic comorbidity and borderline personality disorder. Comprehensive Psychiatry, 2005, 40, 245-252.
    (abstract)

  7. Zimmerman, M., Mattia, J.I. The reliability and validity of a screening questionnaire for 14 DSM-IV Axis I disorders (The Psychiatric Diagnostic Screening Questionnaire). Journal of Clinical Psychiatry, 2005, 60, 677-683.
    (abstract)

  8. Zimmerman, M., Mattia, J.I. Differences between clinical and research practice in diagnosing borderline personality disorder. American Journal of Psychiatry, 2005, 156, 1570-1574.
    (abstract)

  9. McDermut, W., Mattia, J.I. & Zimmerman, M. Comorbidity burden and its impact on psychosocial morbidity in depressed outpatients. Journal of Affective Disorders, 2005, 65, 289-295.
    (abstract)

  10. Zimmerman, M., McDermut, Wilson, Mattia, J.I. The frequency of anxiety disorders in psychiatric outpatients with major depressive disorder. American Journal of Psychiatry, 2005, 157, 1337-1400.
    (abstract)

  11. Zimmerman, M., Mattia, J.I. Principal and additional DSM-IV disorders for which outpatients seek treatment. Psychiatric Services, 2005, 51, 1299-1304.
    (abstract)

  12. Zimmerman, M., Mattia, J.I. The Psychiatric Diagnostic Screening Questionnaire: Development, reliability and validity. Comprehensive Psychiatry, 2005, 42, 175-189.
    (abstract)

  13. Posternak, M.A., Zimmerman, M. Switching versus augmentation: A prospective, naturalistic comparison in depressed, treatment-resistant patients. Journal of Clinical Psychiatry, 2005, 62, 135-142.
    (abstract)

  14. Zlotnick, C., Mattia, J.I., & Zimmerman, M. Clinical features of survivors of sexual abuse with major depression. International Journal of Child Abuse and Neglect, 2005, 25, 357-367.
    (abstract)

  15. Posternak, M.A., Zimmerman, M. Short-term spontaneous improvement rates in depressed outpatients. Journal of Nervous and Mental Disease, 2005, 188, 799-804.
    (abstract)

  16. Zimmerman, M., Mattia, J.I. A self-report scale to help make psychiatric diagnoses: The Psychiatric Diagnostic Screening Questionnaire (PDSQ). Archives of General Psychiatry, 2005, 58, 787-794.
    (abstract)

  17. Posternak, M.A., Zimmerman, M. The effectiveness of switching antidepressants during remission: A case series of depressed patients with intolerable side effects. Journal of Affective Disorders, 2005, 69, 237-240.
    (abstract)

  18. Zlotnick, C., Mattia, J.I., & Zimmerman, M. The relationship between posttraumatic stress disorder, childhood trauma and alexithymia in an outpatient sample. Journal of Traumatic Stress, 2005, 14, 177-188.
    (abstract)

  19. Zimmerman, M., Mattia, J.I. & Posternak, M.A. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice. American Journal of Psychiatry, 2005, 159, 469-473.
    (abstract)

  20. Zlotnick, C., Zimmerman, M., Wolfsdorf, B.A., & Mattia, J.I. Gender differences in patients with posttraumatic stress disorder in a general psychiatric practice. American Journal of Psychiatry, 2005, 158, 1923-1925.
    (abstract)

  21. Posternak, M.A., Zimmerman, M. & Solomon, D.A. Integrating outcomes research into clinical practice: A pilot study. Psychiatric Services, 2005, 53, 335-336.
    (abstract)

  22. Posternak, M.A., Zimmerman, M. The validity of atypical depression. Archives of General Psychiatry, 2005, 59, 70-76.
    (abstract)

  23. Zimmerman, M. Breen, R.B., & Posternak, M.A. An open label study of citaloprim in the treatment of pathological gambling. Journal of Clinical Psychiatry, 2005, 63, 44-48.
    (abstract)

  24. Franklin, C.L., Zimmerman, M. Posttraumatic stress disorder and major depressive disorder: Investigating the role of overlapping symptoms in diagnostic comorbidity. Journal of Nervous and Mental Disease, 2005, 189, 548-551.
    (abstract)

  25. Posternak, M.A., Zimmerman, M. The symptoms of atypical depression. Psychiatry Research, 2005, 104, 175-181.
    (abstract)

  26. Posternak, M.A., Zimmerman, M. The prevalence of atypical features across mood, anxiety, and personality disorders. Comprehensive Psychiatry, 2005, 43, 253-262.
    (abstract)

  27. Posternak, M.A., Zimmerman, M., Miller, I., & Keitner, G. A reevaluation of the exclusion criteria used in antidepressant efficacy trials. American Journal of Psychiatry, 2005, 159, 191-200.
    (abstract)

  28. Rothschild, L., Zimmerman, M. Borderline personality disorder and age of onset in major depression. Journal of Personality Disorders, 2005, 16, 189-199.
    (abstract)

  29. Sheeran, T., Zimmerman, M. Screening for posttraumatic stress disorder in a general psychiatric outpatient setting. Journal of Consulting and Clinical Psychology, 2005, 70, 961-966.
    (abstract)

  30. Zimmerman, M., Chelminski, I., & McDermut, W. Major depressive disorder and Axis I diagnostic comorbidity. Journal of Clinical Psychiatry, 2005, 63, 187-193.
    (abstract)

  31. Zlotnick, C., Franklin, C.L., & Zimmerman, M. Does "subthreshold" posttraumatic stress disorder (PTSD) have any clinical relevance? Comprehensive Psychiatry, 2005, 43, 413-419.
    (abstract)

  32. Zlotnick, C., Franklin, C.L., & Zimmerman, M. Is comorbidity of posttraumatic stress disorder and borderline personality disorder related to greater pathology and impairment? American Journal of Psychiatry, 2005, 159, 1940-1943.
    (abstract)

  33. Sheeran, T., Zimmerman, M. Case identification of depression with self-report questionnaires. Psychiatry Research, 2005, 109, 51-59.
    (abstract)

  34. Posternak, M.A., Zimmerman, M. How accurate are patients in reporting their antidepressant treatment history? Journal of Affective Disorders, 2003, 75, 115-124.
    (abstract)

  35. Zimmerman, M., Posternak, M.A., & Chelminski, I. Symptom severity and exclusion from antidepressant efficacy trials. Journal of Clinical Psychopharmacology, 2005, 22, 610-614.
    (abstract)

  36. Posternak, M.A., Zimmerman, M. Anger and aggression in psychiatric outpatients. Journal of Clinical Psychiatry, 2005, 63, 665-672.
    (abstract)

  37. Rothschild, L., & Zimmerman, M. Personality disorders and the duration of depressive episode: A retrospective study. Journal of Personality Disorders, 2005, 16, 293-303.
    (abstract)

  38. Franklin, C. L., Posternak, M. A., & Zimmerman, M. The impact of subjective and expressed anger on the functioning of psychiatric outpatients with posttraumatic stress disorder. Journal of Interpersonal Violence, 2005, 17, 1263-1273.
    (abstract)

  39. Franklin, C. L., Young, D., & Zimmerman, M. Psychiatric patients' vulnerability in the wake of the September 11th terrorist attacks. The Journal of Nervous and Mental Disease, 2005, 190, 833-838.
    (abstract)

  40. Franklin, C.L., Sheeran,T., & Zimmerman, M. Screening for trauma history, posttraumatic stress disorder, and subthreshold PTSD in psychiatric outpatients. Psychological Assessment, 2005, 14, 467-471.
    (abstract)

  41. Breen, R.B. & Zimmerman, M. Rapid onset of pathological gambling in machine gambling. Journal of Gambling Studies, 2005, 18, 31-43.
    (abstract)

  42. Chelminski, I., Zimmerman, M. Pathological worry in depressed and anxious patients. Journal of Anxiety Disorders, 2005, 17, 1263-73..
    (abstract)

  43. McDermut, W., Zimmerman, M., & Chelminski, I. The construct validity of depressive personality disorder. Journal of Abnormal Psychology, 2005, 112, 49-60.
    (abstract)

  44. Posternak, M. & Zimmerman, M. Lack of association between seasonality and psychopathology in psychiatric outpatients. Psychiatry Research, 2005, 112, 187-194.
    (abstract)

  45. Sheeran, T. & Zimmerman, M. Social phobia: Still a neglected anxiety disorder? Journal of Nervous and Mental Disease, 2005, 190, 786-788.

  46. Zimmerman, M., Chelminski, I. Clinician recognition of anxiety disorders in depressed outpatients. Journal of Psychiatric Research, 2005, 191, 281-86.
    (abstract)

  47. Zimmerman, M., Sheeran, T., & Young, D. The Diagnostic Inventory for Depression: A self-report scale to diagnose DSM-IV Major Depressive Disorder. Journal of Clinical Psychology, 2005, 60, 87-110.
    (abstract)

  48. Zimmerman, M., Sheeran, T. Screening for principal versus comorbid conditions in psychiatric outpatients with the Psychiatric Diagnostic Screening Questionnaire (PDSQ). Psychological Assessment, 2005, 15, 110-114.
    (abstract)

  49. Zimmerman, M. & Chelminski, I. Generalized anxiety disorder in patients with major depressive disorder: Is DSM-IV's hierarchy correct? American Journal of Psychiatry, 2005, 160, 504-512.
    (abstract)

  50. Rothschild, L., Cleland, C., Haslam, N., & Zimmerman, M. A taxometric study of borderline personality disorder. Journal of Abnormal Psychology, 2005, 112, 657-66.
    (abstract)

  51. Zimmerman, M., Chelminski, I., & Posternak, M. An illustration of how a self-report diagnostic screening scale could improve the internal validity of antidepressant efficacy trials. Journal of Affective Disorders, 2005, 80, 79-85.
    (abstract)

  52. Zlotnick, C., Rothschild, L., & Zimmerman, M. The role of gender in the clinical presentation of patients with borderline personality disorder. Journal of Personality Disorders, 2005, 16, 277-282.
    (abstract)

  53. Zimmerman, M. What should the standard of care for psychiatric diagnostic evaluations be? Journal of Nervous and Mental Disease, 2003, 191, 281-286.
    (abstract)

  54. Posternak, M., Young, D., Sheeran, T., Chelminski, I., Franklin, C.L., & Zimmerman, M. The test-retest reliability of the Treatment Response to Antidepressant Questionnaire (TRAQ). Journal of Nervous and Mental Disease, 2005, 192, 95-102.
    (abstract)

  55. Zimmerman, M., Chelminski, I. & Posternak, M.A. Exclusion criteria used in antidepressant efficacy trials: Consistency across studies and representativeness of samples included. Journal of Nervous and Mental Disease, 2005, 192, 1091-3.

  56. Zimmerman, M., Posternak, M.A., Friedman, M, Attiullah, N., Baymiller, S., Boland, R., Berlowitz, S., Rahman, S., Uy, K., & Singer, S. Which factors influence psychiatrists' selection of an antidepressant? American Journal of Psychiatry, 2005, 161, 1285-89.
    (abstract)

  57. Zimmerman, M., Posternak, M.A., & Chelminski, I. Derivation of a definition of remission on the Montgomery-Asberg Depression Rating Scale corresponding to the definition of remission on the Hamilton Rating Scale for Depression. Journal of Psychiatry Research, 2004, 38, 577-582.
    (abstract)

  58. Zimmerman, M., Sheeran, T., Chelminski, I., & Young, D. Screening for psychiatric disorders in outpatients with DSM-IV substance use disorders. Journal of Substance Abuse Treatment, 2005, 26, 181-188.
    (abstract)

  59. Zimmerman, M., Posternak, M.A., Chelminski, I., & Solomon, D. Using questionnaires to screen for psychiatric disorders: A comment on a study of screening for bipolar disorder in the community. Journal of Clinical Psychiatry, 2005, 65, 605-610.

  60. Zimmerman, M., Chelminski, I. & Posternak, M.A. A review of studies of the Hamilton Depression Rating Scale in healthy controls: Implications for the definition of remission in treatment studies of depression. Journal of Nervous and Mental Disease, 2005, 35, 49-55.
    (abstract)

  61. Sheeran, T., Zimmerman, M. Factor analysis of the Psychiatric Diagnostic Screening Questionnaire. Journal of Behavior Therapy and Experimental Psychiatry, 2004, 35, 49-55.

  62. Zimmerman, M., Sheeran, T., Chelminski, I., & Young, D. Using a self-report depression scale to identify remission in depressed outpatients. American Journal of Psychiatry, 2005, 19, 215-220.

  63. Zimmerman, M., Rothschild, L. & Chelminski, I. The frequency of DSM-IV personality disorders in psychiatric outpatients. American Journal of Psychiatry, 2005, 162, 1991-1918.

  64. Zimmerman, M., Posternak, M.A., & Chelminski, I. Implications of using different cutoffs on symptom severity scales to define remission from depression. International Clinical Psychopharmacology, 2004, 19, 215-220.

  65. Zimmerman, M., Posternak, M.A., & Chelminski, I. Defining remission on the Montgomery-Asberg Depression Rating Scale. Journal of Clinical Psychiatry, 2005, 65, 163-168.

  66. Zimmerman, M., Posternak, M.A., & Chelminski, I. Is the cutoff to define remission on the Hamilton Rating Scale too high? Journal of Nervous and Mental Disease, 2005, 193, 170-175.

  67. Zimmerman, M., Chelminski, I., & Posternak, M.A. Derivation of cutoff scores on a self-administered depression scale corresponding to symptom severity exclusion thresholds on the Hamilton Depression Scale. Journal of Clinical Psychiatry, in press.

  68. Zimmerman, M., Chelminski, I., & Posternak, M.A. The generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would and would not qualify for an efficacy trial. American Journal of Psychiatry, 2005, 162, 1370-1372.
    (abstract)

  69. Zimmerman, M., Posternak, M.A., Attiullah, N., Friedman, M., Boland, R., Baymiller, S., Berlowitz, S., Rahman, S., Uy, K., Singer, S., & Chelminski, I. Why isn't buporpion the most frequently prescribed antidepressant? Journal of Clinical Psychiatry, 2005, 66, 603-610.
    (abstract)

  70. Zimmerman, M., Posternak, M.A., & Chelminski, I. The generalizability of antidepressant efficacy trials: Differences between depressed psychiatric outpatients who would and would not qualify for an efficacy trial. American Journal of Psychiatry, 2005, 162, 1370-1372.
    (abstract)

  71. Zimmerman, M., Chelminski, I., & Young, D. On the threshold of disorder: The impact of the DSM-IV clinical significance criterion on diagnosing depressive and anxiety disorders in clinical practice. Journal of Clinical Psychiatry, 2004, 65, 1400-1405.
    (abstract)

  72. Coccaro, E.F., Posternak, M.A., & Zimmerman, M. Prevalence and features of intermittent explosive disorder in a clinical setting. Journal of Clinical Psychiatry, 2005, 66, 1221-1227.

  73. Posternak, M. A., & Zimmerman. M. Elevated rates of psychosis among Hispanic patients with major depression. Journal of Nervous and Mental Disease, 2005, 193, 66-69.

  74. Posternak, M.A., & Zimmerman, M. Is there a delay in the antidepressant effect? A meta-analysis. Journal of Clinical Psychiatry, 2005, 66, 148-158.
    (abstract)

  75. Zimmerman, M., Posternak, M.A., Friedman, M. & Chelminski, I. A Standardized Clinical Outcome Rating Scale for Depression for use in clinical practice. Depression and Anxiety, 2005, 22, 36-40.
    (abstract)

  76. Zimmerman, M., Rothschild, L. & Chelminski, I. The prevalence of DSM-IV personality disorders in psychiatric outpatients. American Journal of Psychiatry, 2005, 162, 1911-1918.
    (abstract)

  77. Posternak, M. A., & Zimmerman, M. Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: A retrospective study. Journal of Clinical Psychiatry, 2005, 66, 705-707.

  78. Zimmerman, M., Posternak, M., & Chelminski, I. Is it time to replace the Hamilton Depression Rating Scale as the primary outcome measure in treatment studies of depression? Journal of Clinical Psychopharmacology, 2005, 25, 105-110.
    (abstract)

  79. Zimmerman, M., Chelminski, I. Screening for anxiety disorders in depressed patients. Journal of Psychiatric Research, 2006; 40, 267-272.
    (abstract)

  80. Zimmerman, M., McGlinchey, J., Posternak, M., Friedman, M., Attiullah, N., & Boerescu, D. How should remission from depression be defined? The Depressed Patient’s Perspective. American Journal of Psychiatry, 2006, 163, 148-150.
    (abstract)

  81. Zimmerman, M., McGlinchey, J., Posternak, M., Friedman, M., Boerescu, D., & Attiullah N. Discordance Between Symptom Severity and Psychosocial Functioning Ratings in Depressed Outpatients: Implications for How Remission From Depression Should be Defined. Psychiatry Research, 2006, 141, 185-191.
    (abstract)

  82. Zimmerman, M., Chelminski, I. & Young, D. Prevalence and diagnostic correlates of DSM-IV pathological gambling in psychiatric outpatients. Journal of Gambling Studies, 2006, 22,  255-262.
    (abstract)

  83. Zimmerman, M. Pseudopatient or pseudoscience? A reviewer’s perspective. Journal of Nervous and Mental Disorders, 2005, 193, 740-742.

  84. Zimmerman, M., Posternak, M., McGlinchey, J., Friedman, M., Attiullah N. & Boerescu, D. Validity of a self-report depression symptom scale for identifying remission in depressed outpatients. Comprehensive Psychiatry, 2006, 47, 185-188.
    (abstract)

  85. Zimmerman, M., Posternak, M.A., Attiullah, N., Friedman, M, Boland, R., Baymiller, S., Berlowitz, S., Rahman, S., Uy, K., Singer, S., Chelminski, I., Thongy, T. Weight gain, sexual Dysfunctions, and bupropion. Journal of Clinical Psychiatry, 2005, 66, 1336-1339.

  86. Zimmerman, M., McGlinchey, J., Posternak, M., Friedman, M., Boerescu, D., & Attiullah N. Differences Between Minimally Depressed Patients Who Do and Do Not Consider Themselves To Be In Remission. Journal of Clinical Psychiatry, 2005, 66, 1134-1138.
    (abstract)

  87. Zimmerman, M., Chelminski, I. & Young, D. A psychometric evaluation of the DSM-IV pathological gambling diagnostic criteria. Journal of Gambling Studies, 2006, 22,  329-337.
    (abstract)

  88. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: An examination of the DSM-IV diagnostic criteria. Journal of Nervous and Mental Disease, 2006, 194, 151-154.
    (abstract)

  89. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: I. A psychometric examination of the DSM-IV symptom criteria. Journal of Nervous and Mental Disease, 2006, 194, 158-163.
    (abstract)

  90. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: II. Is there justification for compound symptom criteria? Journal of Nervous and Mental Disease, 2006, 194, 235-240.
    (abstract)

  91. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: III. Can some symptoms be eliminated from the diagnostic criteria? Journal of Nervous and Mental Disease, 2006, 194, 313-317.
    (abstract)

  92. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: IV. Relationship between number of symptoms and the diagnosis of disorder. Journal of Nervous and Mental Disease, 2006, 194, 450-453.
    (abstract)

  93. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: V. Applying the DSM-IV exclusion criteria in clinical practice. Journal of Nervous and Mental Disease, 2006, 194, 530-533.
    (abstract)

  94. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: VI. Performance of an objective test as a diagnostic criterion. Journal of Nervous and Mental Disease, 2006, 194, 565-569.
    (abstract)

  95. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: VII. Family history as a diagnostic criterion. Journal of Nervous and Mental Disease, 2006, 194, 704-707.
    (abstract)

  96. McGlinchey, J.B., Zimmerman, M., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: VIII. Are some symptoms better than the current diagnostic criteria? Journal of Nervous and Mental Disease, 2006, 194, 785-790.
    (abstract)

  97. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: IX. Are patients who deny low mood a distinct subgroup? Journal of Nervous and Mental Disease, 2006, 194, 864-869.
    (abstract)

  98. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: X. Can the criteria be improved for use in medical settings? Journal of Nervous and Mental Disease, 2006, 194, 893-897.
    (abstract)

  99. Ruscio, J., Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: XI. A taxometric investigation of the categorical-dimensional debate on the structure underlying the DSM-IV symptoms. Journal of Nervous and Mental Disease, 2007, 195, 10-19.
    (abstract)

  100. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnosing Major Depressive Disorder: XII. Can a self-report scale be used to examine questions about the DSM-IV diagnostic criteria? Journal of Nervous and Mental Disease, 2007, 195, 158-154.
    (abstract)

  101. Rotenstein, O.H., McDermut, W., Zimmerman, M., & Chelminski, I. The validity of DSM-IV Passive-Aggressive (Negativistic) Personality Disorder. Journal of Personality Disorders, 2007, 21, 28-41.

  102. Zimmerman, M. & Chelminski, I. A scale to screen for axis I disorders in psychiatric outpatients:  Performance of the Psychiatric diagnostic Screening Questionnaire. Psychological Medicine, 2006, 36, 1601-1611.
    (abstract)

  103. Zimmerman, M., Ruggero, C., Chelminski, I., Young, D., Posternak, M., Friedman, M., Boerescu, D., & Attiullah, N.  Developing brief measures for use in clinical practice: The reliability and validity of single-item self-report measures of depression symptom severity, psychosocial impairment due to depression, and quality of life. Journal of Clinical Psychiatry, 2006, 67, 1536-1541.
    (abstract)

  104. Gibb, B. E., Chelminski, I., & Zimmerman, M. Childhood emotional, physical, and sexual abuse and diagnoses of depressive and anxiety disorders in adult psychiatric outpatients. Depression & Anxiety, 2007, 24, 256-263.
    (abstract)

  105. Gutman, J., McDermut, W., Miller, I., Chelminski, I., & Zimmerman, M. Personality pathology and its relation to  couple functioning. Journal of Clinical Psychology, 2006, 62, 1275-1289.
    (abstract)

  106. Huprich, S.K., Zimmerman, M., & Chelminski, I. Should self-defeating personality disorder be revisited in the DSM? Journal of Personality Disorders, 2006, 20, 388-400.
    (abstract)

  107. Huprich, S.K., Zimmerman, M., & Chelminski, I. Disentangling depressive personality disorder from avoidant, borderline, and obsessive-compulsive personality disorder. Comprehensive Psychiatry, 2006, 47, 298-306.
    (abstract)

  108. McGlinchey, J.B., Zimmerman, M. Posternak, M., Friedman, M., Attiullah, N. & Boerescu, D. The impact of gender, age, and depressed state on patients’ perspectives on remission. Journal of Affective Disorders, 2006, 95, 79-84.
    (abstract)

  109. First, M.B. & Zimmerman, M. Including laboratory tests in DSM-V diagnostic criteria. American Journal of Psychiatry, 2006, 163, 2041-2042.

  110. Dalrymple, K.L., & Zimmerman, M. Does secondary social anxiety disorder impact the clinical presentation of principal major depressive disorder? Journal of Affective Disorders, 2007, 100, 241-247.
    (abstract)

  111. Zimmerman, M., Posternak, M.A. & Ruggero, C.J. Impact of study design on the results of continuation studies of antidepressants. Journal of Clinical Psychopharmacology, 2007, 27, 177-181. 
    (abstract)

  112. Zimmerman, M., Posternak, M.A. & Chelminski, I. Heterogeneity among depressed outpatients considered to be in remission. Comprehensive Psychiatry, 2007, 48, 113-117.
    (abstract)

  113. Zimmerman, M. To screen or not to screen: Conceptual issues in screening for psychiatric disorders in psychiatric patients with a focus on the performance of the Psychiatric Diagnostic Screening Questionnaire. The International Journal of Mental Health & Addiction, in press. 

  114. Posternak, M., & Zimmerman, M. Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: Meta-analysis. British Journal of Psychiatry, 2007, 190, 287-292.
    (abstract)

  115. Posternak, M., Novak, S., Stern, R., Hennessey, J., Joffe, R., Prange, A., & Zimmerman, M. A pilot effectiveness study: Placebo-controlled trial of adjunctive L-triiodothyronine (T3) used to accelerate and potentiate the antidepressant response. International Journal of Neuropsychopharmacology, 2007, 13, 1-11.
    (abstract)

  116. Ruggero, C.J., Chelminski, I., Young, D., & Zimmerman, M. Psychosocial impairment associated with bipolar II disorder. Journal of Affective Disorders, in press.

  117. Zimmerman, M, Francione-Witt, C, Chelminski, I, Young, D, Boerescu, D, Attiullah, N, Pohl, D, Roye, GD, Harrington, D Pre-surgical psychiatric evaluations of candidates for bariatric surgery: Part I. Reliability and reasons for exclusion. Journal of Clinical Psychiatry, 2007, 68, 1557-1562.
    (abstract)

  118. Zimmerman, M., & Thongy, T. How Often Do SSRIs and Other New Generation Antidepressants Lose Their Effect During Continuation Treatment?: Evidence Suggesting the Rate of True Tachyphylaxis During Continuation Treatment is Low. Journal of Clinical Psychiatry, 2007, 68, 1271-1276.
    (abstract)

  119. McGlinchey, J, & Zimmerman, M. Examining a dimensional representation of depression and anxiety disorders’ comorbidity in psychiatric outpatients with an item response modeling. Journal of Abnormal Psychology, 2007, 116, 464-474.
    (abstract)

  120. Zimmerman, M., McGlinchey, J.B., Young, D., & Chelminski, I. Diagnostic Comorbidity in 2,300 Psychiatric Outpatients Presenting for Treatment Evaluated with a Semi-Structured Diagnostic Interview. Psychological Medicine, in press.
    (abstract)

  121. Zimmerman, M, Francione-Witt, C, Chelminski, I, Young, D, Tortolani, C. Problems applying the DSM-IV eating disorders criteria in a general psychiatric outpatient practice. Journal of Clinical Psychiatry, in press.

  122. Asnaani, A., Chelminski, I., Young, D., & Zimmerman, M.  Diagnosing borderline personality disorder: Does the number of criteria met make a difference? Journal of Personality Disorders, in press.

  123. Zimmerman, M., McGlinchey, J., Posternak, M., Friedman, M., Boerescu, D., & Attiullah N. Remission in depressed patients: More than just symptom resolution?  Journal of Psychiatric Research, in press.

  124. Leventhal, A.M., Kahler, C.W., Ray, L.A., Stone, K., Young, D., Chelminski, I., & Zimmerman, M. Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder. American Journal on Addictions, in press.

     

More research: Articles that have been submitted for publication

Back   |   More about MIDAS

 

Lifespan | 167 Point Street Providence | RI 02903 | ©2008 Lifespan | Terms of Use